
Using CRISPR researchers have identified 86 genes that could be associated with HIV replication and disease, opening doors to research…
Using CRISPR researchers have identified 86 genes that could be associated with HIV replication and disease, opening doors to research…
The first female, nonwhite and HIV-positive cancer patient treated with a new stem-cell transplant therapy is now in long-term remission…
Researchers demonstrate the value of nucleic acid technology in encoding immunogens capable of eliciting tier-2 neutralizing antibodies against HIV in the race to develop…
Sometimes in experimental biology the very factor that is part of the disease-causing mechanism can also be the factor that…
A new mRNA HIV vaccine technology encodes key proteins to form virus-like particles (VLPs) that induce neutralizing antibodies safely and effectively in animal studies with minimal side effects. Researchers from…
This review, recently published in our partner journal Future Microbiology, discusses the pharmacology of oteseconazole and summarizes clinical studies investigating…
New encapsulating technology for whole-cell vaccines stimulates enhanced immunogenicity against Escherichia coli in a mouse model, shaping the future of urinary tract infection (UTI) vaccines. Recurrent…
Plant natural products represent a largely untapped resource for discovering bioactive compounds to fill the antimicrobial drug development pipeline. With…
A historic moment: WHO recommends deployment of a malaria vaccine finally developed after a 100-year endeavour. The WHO have advised that the RTS,S/AS01 vaccine, also known as Mosquirix, developed by GlaxoSmithKline (London, England) over the last 30 years in…
Researchers discover bacteriophage ‘Muddy’ and antibiotic rifabutin as a new dynamic duo combination therapy against antibiotic-resistant Mycobacterium abscessus infection in a cystic fibrosis zebrafish model. A group of researchers…